Arcline Investment Management Acquires ChargePoint Technology

Growth-oriented private equity firm, Arcline Investment Management, has acquired sterile and contained pharmaceutical product transfer specialist, ChargePoint Technology, strengthening global presence.

According to a March 1, 2021 press release, the deal will involve the incorporation of ChargePoint Technology into Arcline’s broader specialty process technologies platform offering to support global customers. Through the acquisition, ChargePoint Technology will be able to further progress its development pipeline in enhanced sterile and contained process solutions. Additionally, it is expected that Arcline will be making several other acquisitions to support ChargePoint’s process technology platform and create a tailored biopharma processing offering.

“Partnering with Arcline is an incredible opportunity for us to further strengthen our commitment to delivering high-quality world class process solutions for our customers,” said Chris Eccles, CEO at ChargePoint Technology, in the press release. “Arcline share our energy, focus, and passion, a powerful synergy, which will further catalyze the innovation of our products and improve the support we offer customers across the globe. We look forward to working with the team at Arcline to build the process solution platforms of the future.”

Source: ChargePoint Technology